PSTV vs QRVO · P/E 0.2, rev $5.8M vs P/E 27, rev $3.68B
Plus Therapeutics Inc (PSTV) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the PSTV and QRVO stock pages for the full models.
Not investment advice.